• Mashup Score: 0

    Purpose An ASCO provisional clinical opinion (PCO) offers timely clinical direction to ASCO’s membership and other health care providers. This PCO addresses identification and management of patients and family members with possible predisposition to pancreatic adenocarcinoma. Methods ASCO convened an Expert Panel and conducted a systematic review of the literature published from January 1998 to June 2018. Results of the databases searched were supplemented with hand searching of the bibliographies of systematic reviews and selected seminal articles and contributions from Expert Panel members’ curated files. Provisional Clinical Opinion All patients diagnosed with pancreatic adenocarcinoma should undergo assessment of risk for hereditary syndromes known to be associated with an increased risk for pancreatic adenocarcinoma. Assessment of risk should include a comprehensive review of family history of cancer. Individuals with a family history of pancreatic cancer affecting two first-degre

    Tweet Tweets with this article
    • Here is the @asco statement: https://t.co/WKKudtZRSi

  • Mashup Score: 0

    100% for the cure!

    Tweet Tweets with this article
    • My 10th year @bikeVeloSano! A fantastic way to connect with our community & for researchers/ trainees to get much-needed pilot funds. If able, please consider donating. 100% of $ raised go to cancer research! https://t.co/Uj4o0tmqYX https://t.co/1NuFKev0px